生物制药公司 ANEW Medical 与 Redwood Acquisition 完成业务合并，在纳斯达克以“WENA”代码交易。 Biopharmaceutical firm ANEW Medical completes business combination with Redwood Acquisition, trading under "WENA" on Nasdaq.
生物制药公司 ANEW Medical, Inc. 和特殊目的收购公司 Redwood Acquisition Corp. 已完成业务合并。 Biopharmaceutical firm ANEW Medical, Inc. and special purpose acquisition company Redwood Acquisition Corp. have completed their business combination. 合并后的公司将被命名为 ANEW Medical, Inc.，并在纳斯达克全球市场以股票代码“WENA”和“WENAW”进行交易。 The combined company, to be named ANEW Medical, Inc., will trade on the Nasdaq Global Market under the tickers "WENA" and "WENAW". ANEW 专注于开发中枢神经系统和神经退行性疾病的治疗方法。 ANEW focuses on developing treatments for the central nervous system and neurodegenerative diseases.